<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link rel="shortcut icon" href="../images/favicon.png" type="image/x-icon">
  <title>Nephroblastoma</title>
  <link href="https://cdn.jsdelivr.net/npm/remixicon@2.5.0/fonts/remixicon.css" rel="stylesheet">
  <link rel="stylesheet" href="../style.css">
  <link rel="stylesheet" href="../notes.css">

</head>
<body>
  <input type="checkbox" id="main-navigation-toggle" class="btn btn--close" title="Toggle main navigation" />
  <label for="main-navigation-toggle">
    <span></span>
  </label>
  
  <a href="../index.html">
   <div class="home-navigation">
      mtr<span class="logo-dot">.</span>
    </div>
  </a>


    <nav id="main-navigation" class="nav-main">
    <ul class="menu">
      <li class="menu__item">
        <a class="menu__link" href="../index.html">Home</a>
      </li>

      <li class="menu__item">
        <a class="menu__link" href="../about-temp2.html">About</a>
      </li>
    </ul>
  </nav>
  
      <!-- Toggle switch for dark mode -->
      <div class="dark-mode-toggle">
        <label class="switch-toggle">
            <input type="checkbox" id="dark-mode-toggle-checkbox">
            <span class="toggle-slider"></span>
        </label>
      </div>

      <!-- Progress Bar  -->
      <div id="progress-container">
        <div id="progress-bar"></div>
    </div>
      
<!-- SIDEBAR -->
<div id="sidebar" class="sidebar">
  <button id="closeSidebarBtn" class="btn toggle-btn close-btn">Close</button>
  <ul class="sidebar-menu toggle-menu">
    <!-- Add the list of topics dynamically using JavaScript -->
  </ul>
</div>

<!-- Toggle button to open the sidebar -->
<button id="toggleSidebarBtn" class="btn toggle-btn">&#9776;</button>

<!-- END OF SIDEBAR -->

  <main class="page-container">
    <div class="contribute-cta">
      <p>Help make this betterüíú</p>
      <span><a href="../contribute.html">Contribute here</a> </span>
    </div>


  <!-- TOPIC AND IMAGE CONTAINER  -->

  <h1>Nephroblastoma</h1>


  <!-- END OF TOPIC AND IMAGE CONTAINER  -->
  


    <article class="notes">
        <a id='top'></a>
    <article>

          <!-- LEARNING OBJECTIVES CONTAINER  -->
              <div class="custom-card" id="custom-card-1">
                <div class="icon"><img src="../images/icons/light-bulb.png" alt="Icon" class="icon"></div>
                <div class="title"> 
                  <h2>What You Will Learn</h2>
                </div>
                <div class="line">
                  <p>After reading this note, you should be able to...</p>
                </div>
                <div class="content">
                  <ul>
                    <li><i>This content is not available yet.</i></li>
                </ul>
                </div>
                <div class="read-more" onclick="toggleContent('custom-card-1')">Read More üç™</div>
              </div>
            
          <!-- END OF LEARNING OBJECTIVES CONTAINER  -->
        
        
          <!-- SHOW AND HIDE OUTLINE CONTAINER  -->
            <div class="outline2">
        
              <input type="radio" name="control-2" id="show-2">
              <label for="show-2">üêµ&nbsp; &nbsp;Show Outline</label>
              <input type="radio" name="control-2" id="hide-2">
              <label for="hide-2">üôà&nbsp; &nbsp; Hide Outline</label>
              <div class="contents">
                <div class="icon-box">
                  <!-- Replace 'path/to/your/icon.png' with the actual path to your PNG icon -->
                  <img src="../images/icons/book.png" alt="Icon" class="icon">
                </div>
                <div id="tableOfContents">
                    <ol id="tocList"></ol>
                </div>
              </div>
             <div>
        
        <!-- END OF SHOW AND HIDE OUTLINE CONTAINER  -->
        
        
          <br>
        
            <!-- BEGINNING OF NOTE -->
        
      <section id='header-1'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-1'>Introduction</a>
          </h2>
        </header>
        <div class='body'>

            <ul>
              <li><b>It is a malignant tumor of the developing kidney.</b></li>
              <li><b>It involves the embryonal cells in the kidney.</b></li>
              <li><b>It is the most common renal tumor in children.</b></li>
              <li>Also called <b>Wilm‚Äôs tumor (WT)</b>.</li>
            </ul>
            
        </div>
      </section>

      <section id='header-2'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-2'>Epidemiology</a>
          </h2>
        </header>
        <div class='body'>

            <ul>
              <li><b>Peak age at diagnosis</b> is between 3 years and 4 years</li>
              <li><b>Mean age at diagnosis</b> is 3.5 years</li>
              <li>Most cases (<b>80%</b>) are diagnosed before 5 years of age</li>
              <li>No sex predilection</li>
              <li>Most cases are <b>sporadic</b> (not related to any hereditary or genetic tendency)</li>
              <li>Only about <b>2.5%</b> are familial</li>
            </ul>
            

        </div>
      </section>

      <section id='header-3'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-3'>Etiology</a>
          </h2>
        </header>
        <div class='body'>

            <p>The clinical settings include:</p>
            
            <ul>
              <li><b>Sporadic</b></li>
              <li><b>Familial</b></li>
            </ul>
            
            <p>Associated with genetic syndromes (<b>12-15%</b>):</p>
            
            <ul>
              <li><b>Familial type</b> is associated with genito-urinary abnormalities such as:
                <ul>
                  <li>Hypospadias</li>
                  <li>Cryptorchidism</li>
                  <li>Ureteral duplication</li>
                  <li>Polycystic kidneys</li>
                </ul>
              </li>
            </ul>
            
            <p>The genetic syndromes that may be associated with WT include:</p>
            
            <ul>
              <li><b>Beckwith-Wiedemann syndrome</b></li>
              <li><b>Unilateral hemihypertrophy</b></li>
              <li><b>Aniridia</b></li>
            </ul>
            
            <ul>
              <li><b>The exact etiology is unknown.</b></li>
              <li><b>WT</b> is <b>sporadic</b> in <b>95%</b>; <b>familial</b> in <b>1-2%</b>; <b>bilateral</b> in <b>5-10%</b></li>
              <li><b>2%</b> of WT is associated with syndromes:
                <ul>
                  <li><b>WAGR syndrome</b> (WT, Aniridia, Genitourinary malformation, Mental Retardation)</li>
                  <li><b>Beckwith-Wiedemann syndrome (BWS)</b> (Omphalocele, Macroglossia, Visceromegaly, and embryonal cell tumor)</li>
                  <li><b>Denys-Drash syndrome</b> (WT, Intersex disorder, Nephropathy)</li>
                  <li><b>Perlman syndrome</b> (Overgrowth syndrome with mental retardation)</li>
                </ul>
              </li>
              <li>Other associated anomalies seen in WT include isolated hemihypertrophy, hypospadias, and undescended testes.</li>
              <li>Children with such syndromes should be screened with ultrasound every 6 months until 8 years of age.</li>
            </ul>
            
            <p><b>Genes involved in WT pathogenesis include:</b></p>
            
            <ul>
              <li><b>WT1 gene</b>: A tumor suppressor gene located on 11p13; required for normal kidney and gonadal development. Mutation of this gene is seen in WAGR syndrome, Denys-Drash syndrome, bilateral WT, and <b>10%</b> of sporadic WT.</li>
              <li><b>WT2 gene</b>: Located on 11p15; mutation in the form of deletion or overexpression is linked to familial WT and BWS.</li>
              <li>Additional WT loci include 16q, 1p, and <b>p53</b> (located at 17p13). Mutations in these loci are associated with poor prognosis.</li>
            </ul>
            
        </div>
      </section>

      <section id='header-4'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-4'>Pathophysiology</a>
          </h2>
        </header>
        <div class='body'>

            <ul>
              <li><b>The etiology</b> is unknown.</li>
              <li>The pathophysiology is characterized by an abnormal proliferation of the <b>metanephric blastema</b>.</li>
              <li>Histology shows <b>3 components</b>:
                <ul>
                  <li>Primitive metanephric blastema</li>
                  <li>Dysplastic tubules</li>
                  <li>The mesenchyme</li>
                </ul>
              </li>
              <li>The degree of differentiation of each component determines whether the tumour has <b>favourable</b> or <b>unfavourable</b> histology.</li>
            </ul>
            
            <ul>
              <li>WT can arise anywhere within the kidney.</li>
              <li>It distorts the renal architecture, unlike neuroblastoma which only displaces the kidneys downward without distorting its architecture.</li>
              <li>Spreads beyond a tumour capsule into the <b>renal sinus</b>, <b>intra-renal lymphatics</b>, and <b>blood vessels</b> ‚Üí metastases (commonly to the lungs and liver).</li>
              <li>Vigorous abdominal palpation spills the cells into the abdominal cavity and encourages dissemination.</li>
            </ul>
            
        </div>
      </section>

      <section id='header-5'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-5'>Pathology</a>
          </h2>
        </header>
        <div class='body'>

            <ul>
              <li><b>MACROSCOPY:</b> WT is sharply demarcated and variably encapsulated with <b>haemorrhagic areas</b> and <b>cavitations</b>. Location may be central or polar.</li>
              
              <li><b>MICROSCOPY:</b> Three components seen in normal kidney differentiation‚Äî<b>blastema</b>, <b>tubules</b>, and <b>stroma</b>‚Äîare present. Based on microscopy, there are two broad variants:
                <ul>
                  <li><b>Unfavorable histology:</b> Presence of <b>anaplasia</b>‚Äîcells with nuclear enlargement, hyperchromatic nuclei, and abnormal mitotic figures. Anaplasia is the single most important indicator of poor prognosis.</li>
                  <li><b>Favorable histology:</b> WT without anaplastic features.</li>
                </ul>
              </li>
            </ul>
            
        </div>
      </section>

      <section id='header-6'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-6'>Staging (NWTSG)</a>
          </h2>
        </header>
        <div class='body'>
            <br>
            
            <table class="note-table">
                <tr>
                    <th colspan="2">The National Wilm‚Äôs Tumor Study Group (NWTSG) staging system is universally accepted</th>
                </tr>
                <tr>
                  <th>Stage</th>
                  <th>Description</th>
                </tr>
                <tr>
                  <td><b>Stage I</b></td>
                  <td>Tumor limited to kidney and completely resected</td>
                </tr>
                <tr>
                  <td><b>Stage II</b></td>
                  <td>Tumor extends beyond the kidney but is completely excised</td>
                </tr>
                <tr>
                  <td><b>Stage III</b></td>
                  <td>Residual non-haematogenous tumour confined to the abdomen</td>
                </tr>
                <tr>
                  <td><b>Stage IV</b></td>
                  <td>Haematogenous metastases</td>
                </tr>
                <tr>
                  <td><b>Stage V</b></td>
                  <td>Bilateral tumour</td>
                </tr>
              </table>
              
        </div>
      </section>

      <section id='header-7'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-7'>Clinical Features </a>
          </h2>
        </header>
        <div class='body'>

            <ul>
              <li><b>Asymptomatic flank mass</b> is the most common feature (Crosses the midline in 10% of cases).</li>
              <li>Abdominal pain in <b>30-40%</b> of cases.</li>
              <li>Gross haematuria in <b>5-10%</b> of cases.</li>
              <li>Constipation from pressure effect.</li>

              <li>Severe anaemia with fatigue (secondary to haematuria).</li>
              <li>Mild to moderate hypertension in <b>10%</b> of cases.</li>
              <li>Fever from tumour necrosis.</li>
              <li>Cough.</li>
              <li>Dyspnea from pulmonary metastases.</li>
            </ul>
            
        </div>
      </section>

      <section id='header-8'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-8'>Investigations </a>
          </h2>
        </header>
        <div class='body'>


            <ul>
              <li><b>Ultrasound (abdomen)</b> ‚Äì Initial screening tool.</li>
              <li><b>Intravenous urogram</b> ‚Äì Shows distorted calyces or failure to excrete the dye (non-functional kidney).</li>
              <li><b>Computed tomography scan</b>:
                <ul>
                  <li>Differential diagnosis of a kidney tumour versus adrenal tumour (neuroblastoma).</li>
                  <li>Liver metastases.</li>
                </ul>
              </li>
              <li><b>Chest x-ray</b> ‚Äì As a baseline for pulmonary metastases.</li>
              <li><b>Magnetic resonance imaging</b>.</li>
              <li><b>Biopsy</b> should be avoided to prevent spillage.</li>
            </ul>
            
        </div>
      </section>

      <section id='header-9'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-9'> Treatment</a>
          </h2>
        </header>
        <div class='body'>

            <ul>
              <li><b>It is a potentially curable tumour.</b></li>
              <li><b>Surgical therapy:</b> The first step is surgical staging followed by radical nephrectomy, if possible.</li>
              <li>If the tumour is <b>unresectable</b>, biopsies are performed and the nephrectomy is deferred until after chemotherapy, which will shrink the tumour in most cases.</li>
              <li><b>Adjuvant chemotherapy</b> has improved disease-free survival.</li>
              <li>The <b>cytotoxic agents</b> used are:
                <ul>
                  <li>Vincristine</li>
                  <li>Actinomycin-D</li>
                  <li>Adriamycin</li>
                </ul>
              </li>
              <li><b>Radiotherapy</b> is only useful if there is residual bulk disease after surgery.</li>
            </ul>
            
        </div>
      </section>

      <section id='header-10'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-10'>Differential Diagnosis </a>
          </h2>
        </header>
        <div class='body'>

            <ul>
              <li>Neuroblastoma</li>
              <li>Hepatoblastoma</li>
              <li>Rhabdomyosarcoma</li>
              <li>Benign cystic tumour of the kidney</li>
            </ul>
            
        </div>
      </section>

      <section id='header-11'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-11'>Prognosis </a>
          </h2>
        </header>
        <div class='body'>

            <ul>
              <li>With the advent of multimodal therapy, the prognosis is good.</li>
              <li>The overall cure rate approaches <b>80-85%</b>.</li>
              <li>Cases with diffuse anaplasia and stage III or IV that recur in spite of the complex therapy have a <b>bad prognosis</b>.</li>
            </ul>
            
        </div>
      </section>






      <hr style="margin: 3rem 0;">

      <!-- PRACTICE QUESTIONS CONTAINER -->

      <div class="custom-card" id="custom-card-2">
        <div class="icon"><img src="../images/icons/practice-questions.png" alt="Icon" class="icon"></div>
        <div class="title"> 
          <h2>Practice Questions</h2>
        </div>
        <div class="line">
          <p>Check how well you grasp the concepts by answering the following questions...</p>
        </div>
        <div class="content">
          <ol>
            <li><i>This content is not available yet.</i></li>
          </ol>
        </div>
        <div class="read-more" onclick="toggleContent('custom-card-2')">Read More üç™</div>
      </div>

      <!-- END OF PRACTICE QUESTIONS CONTAINER -->


      <!-- CONTACT- COMMENT AND CONTRIBUTORS CONTAINER -->
      <div class="contact">
        <div class="comment-container">
          <div class="comment-icon">
            <!-- Add your icon image here -->
            <img src="../images/icons/comment.png" alt="Comment Icon">
          </div>
          <div class="comment-text">
            <!-- Add your text here -->
            <p>Send your comments, corrections, explanations/clarifications and requests/suggestions </p>
          </div>
          <a href="https://docs.google.com/forms/d/e/1FAIpQLSdx2teDCmW6ivSeKLQg7zF_jy7Yfg_1Gqm84_UT0PQPATsNug/viewform?usp=sf_link" class="comment-button">
            here
            <!-- <img src="../images/icons/whatsapp.png" alt="Image Icon"> -->
          </a>
        </div>

        <div class="contributors-container">

          <h2 class="contributors-header">Contributors</h2>
  
        <br>
            <div class="contributor-box">
                <img class="contributor-avatar" src="../images/icons/woman.png" alt="Contributor 1 Avatar">
                <div class="contributor-info">
                    <h3 class="contributor-name">Jane Smith</h3>
                    <p class="contributor-description">She is not a real contributor.</p>
                    <div class="social-links">
                        <a href="#" target="_blank" class="social-icon">
                            <img src="../images/icons/whatsapp.png" alt="Social Icon 1">
                        </a>
                        <a href="#" target="_blank" class="social-icon">
                            <img src="../images/icons/twitter.png" alt="Social Icon 2">
                        </a>
                    </div>
                </div>
            </div>
        
            <div class="contributor-box">
                <img class="contributor-avatar" src="../images/icons/man.png" alt="Contributor 2 Avatar">
                <div class="contributor-info">
                    <h3 class="contributor-name">John Doe</h3>
                    <p class="contributor-description">He is not a real contributor.</p>
                    <div class="social-links">
                      <a href="#" target="_blank" class="social-icon">
                        <img src="../images/icons/whatsapp.png" alt="Social Icon 1">
                    </a>
                    <a href="#" target="_blank" class="social-icon">
                        <img src="../images/icons/linkedin.png" alt="Social Icon 2">
                    </a>
                    </div>
                </div>
            </div>
        
        </div>
      </div>

            <!-- END OF CONTACT- COMMENT AND CONTRIBUTORS CONTAINER -->
    </article>
   </article>
   <div style="height: 300px;"></div>
  </main>

  <footer>
    <div class="footer-container">
        <div>
          <p id="popup-trigger">disclaimer</p>

          <!-- The pop-up dive content -->
          <div id="popup" class="popup">
            <p>The contents on this ‚Äòwebsite‚Äô are for educational purposes only. The creators and operators of this website make no warranties, express or implied, regarding the accuracy, currency, or completeness of the information provided on the website. They shall not be held responsible for any errors or omissions, or for any actions taken based on the information provided on this website.</p>
            <button class="popup-close" onclick="closePopup()">Close</button>
          </div>    
          <p><a href="../about-temp2.html">about</a> </p>   
          <p><a href="../contribute.html">contribute</a> </p>
        </div>

        <div class="footer-beta">
          <p>thisisatestversion</p>
        </div>
    </div>
  </footer>
<!------------  SCROLL UP ----------->
<a href="#" class="scrollup" id="scroll-up"> 
  <i class="ri-arrow-up-fill scrollup__icon"></i>
</a>
<script src="../main.js"></script>
<script src="../modal.js"></script>
<script src="../notes-sidebar.js"></script>
</body>
</html>
 
